PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-28.72%
Negative revenue growth while Insurance - Life median is -0.10%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-28.72%
Negative gross profit growth while Insurance - Life median is -0.10%. Seth Klarman would suspect poor product pricing or inefficient production.
-16.01%
Negative EBIT growth while Insurance - Life median is -3.86%. Seth Klarman would check if external or internal factors caused the decline.
-16.01%
Negative operating income growth while Insurance - Life median is -7.41%. Seth Klarman would check if structural or cyclical issues are at play.
-2.39%
Negative net income growth while Insurance - Life median is -0.68%. Seth Klarman would investigate factors dragging net income down.
-2.39%
Negative EPS growth while Insurance - Life median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-2.38%
Negative diluted EPS growth while Insurance - Life median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.58%
Negative OCF growth while Insurance - Life median is 1.63%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-5.58%
Negative FCF growth while Insurance - Life median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
23.36%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 17.25%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
51.46%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 29.87%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
7.58%
3Y revenue/share growth near Insurance - Life median of 7.26%. Charlie Munger would note typical industry expansions over the short term.
110.23%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 19.21% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
76.34%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 11.11%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
12.17%
3Y OCF/share growth > 1.5x Insurance - Life median of 1.41%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
14.28%
Net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm that management’s capital allocation strategy drives the outperformance.
638.77%
5Y net income/share CAGR > 1.5x Insurance - Life median of 18.34%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
11.59%
3Y net income/share CAGR > 1.5x Insurance - Life median of 6.06%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
78.25%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 26.24% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
76.08%
5Y equity/share CAGR > 1.5x Insurance - Life median of 36.10%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
33.40%
3Y equity/share CAGR > 1.5x Insurance - Life median of 18.95%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.15%
AR growth of 25.15% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
-1.70%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-1.06%
Negative BV/share change while Insurance - Life median is 1.08%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
0.71%
Slightly rising debt while Insurance - Life median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
No Data
No Data available this quarter, please select a different quarter.
0.50%
Our SG&A slightly up while Insurance - Life is cutting. Peter Lynch wonders if we overspend or if the median underinvests in marketing.